Nutex Health Addresses Short-Seller Report From Capybara Research, Noting That The Entity Appears Not To Exist And That Prior Lawsuits Against It Were Unserviceable Due To Efforts To Conceal The Identities And Locations Of Those Controlling It

Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), is aware of a short seller report issued on November 25, 2025 by Capybara Research. Based on publicly available information, Capybara Research as an entity seems not to exist.  In the past, lawsuits filed against Capybara by other victims of its abusive tactics could not be served because the person or persons controlling Capybara have taken actions to conceal their identity and location.

The sole purpose of this attack appears to be to create market confusion and to profit from the decline in trading price caused as a result.  Unfortunately, this has become a common short seller tactic that many public companies have encountered.

The allegations in the report appear to be insinuations based on either outdated, inapplicable, incomplete or wrong factual information. 

The Company's material legal proceedings and disputes are described in Part II Item 1--Legal Proceedings of the Company's 10-Q for the period ended September 30, 2025 filed on November 19, 2025 ("Third Quarter 10-Q"), and its related party transactions and policies are described in Note 17 to the Company's Condensed Consolidated Financial Statements contained in the Third Quarter 10-Q and in Amendment No. 1 to our Form 10-K filed on April 30, 2025 in Part III, Item 13. Certain Relationships and Related Persons Transactions, and Director Independence.